T Ruhstaller Selected Research

T Ruhstaller Research Topics

9	Breast Neoplasms (Breast Cancer) 10/2021 - 05/2006
8	Neoplasms (Cancer) 10/2021 - 07/2008
3	Adenocarcinoma 01/2018 - 04/2008
3	Carcinoma (Carcinomatosis) 01/2018 - 09/2009
2	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 09/2009
2	Disease Progression 01/2017 - 04/2011
2	Colorectal Neoplasms (Colorectal Cancer) 07/2008 - 05/2005
1	Amenorrhea 09/2017
1	Stomach Neoplasms (Stomach Cancer) 11/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2009
1	Osteonecrosis (Kienbock's Disease) 12/2008
1	Exanthema (Rash) 07/2008
1	Rectal Neoplasms (Rectal Cancer) 04/2008

3	Letrozole (Femara)FDA LinkGeneric 10/2021 - 04/2011
3	Hormones (Hormone)IBA 10/2021 - 10/2013
3	Capecitabine (Xeloda)FDA Link 11/2010 - 04/2008
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2008 - 05/2005
2	Cetuximab (Erbitux)FDA Link 01/2018 - 07/2008
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 04/2011
2	Bevacizumab (Avastin)FDA Link 01/2011 - 12/2008
2	Cisplatin (Platino)FDA LinkGeneric 11/2010 - 09/2009
1	Estrogens (Estrogen)FDA Link 10/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2017
1	Triptorelin Pamoate (Trelstar)FDA Link 09/2017
1	palbociclibIBA 01/2016
1	lonaprisanIBA 10/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2013
1	Mifepristone (RU 486)FDA Link 10/2013
1	onapristoneIBA 10/2013
1	Aromatase InhibitorsIBA 04/2011
1	Estrogen ReceptorsIBA 04/2011
1	liposomal doxorubicin (Doxil)FDA Link 01/2011
1	1-dodecylpyridoxal (PLD)IBA 01/2011
1	matuzumabIBA 11/2010
1	Epirubicin (Ellence)FDA LinkGeneric 11/2010
1	Docetaxel (Taxotere)FDA Link 09/2009
1	taxaneIBA 09/2009
1	XELOXIBA 07/2008
1	Fluorouracil (Carac)FDA LinkGeneric 05/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2005
1	Leucovorin (Folinic Acid)FDA Link 05/2005